Beta-HCG Levels in Uterine Cavity Lavage for Pregnancies of Unknown Location

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

November 3, 2023

Study Completion Date

November 3, 2023

Conditions
Pregnancy, EctopicEarly Pregnancy Loss
Interventions
DIAGNOSTIC_TEST

Beta-hCG levels in the uterine cavity lavage for differential diagnosis in pregnancy of unknown locations and ectopic pregnancy

The intervention in this study centers on utilizing beta-hCG levels in uterine cavity lavage as a diagnostic tool to differentiate between ectopic pregnancy and early pregnancy loss.The procedure includes females aged 18-45 with positive serum beta-hCG, inconclusive clinical findings, and transvaginal ultrasound results, focusing on beta-hCG levels below 1500-2000 mIU/mL and abnormal progression.The intervention performed before probe curettage (P/C). Before the intervention beta-hCG is measured in venous blood. Patients undergo uterine cavity lavage with 5 ml of saline solution administered and 3 ml of aspirated liquid collected for beta-hCG measurement. Data collection involves beta-hCG levels from lavage fluid and venous blood, pathology results.After the samples were collected, each one was frozen at -80 ºC. All uterine lavage samples were then analyzed later on the same day.

Trial Locations (1)

34668

Zeynep Kamil Women and Children Diseases Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

OTHER

NCT07048587 - Beta-HCG Levels in Uterine Cavity Lavage for Pregnancies of Unknown Location | Biotech Hunter | Biotech Hunter